Estimating Case Fatality and Case Recovery Rates of COVID-19: is this the right thing to do?

Morteza Abdullatif Khafaie, Fakher Rahim

Abstract


Introduction: Case fatality rates (CFRs) and case recovery rates (CRRs) are frequently used to define health consequences related to specific disease epidemics, including the COVID-19 pandemic. This study aimed to compare various methods and models for calculating CFR and CRR related to COVID-19 based on the global and national data available as of April 2020.

Methods: This analytical epidemiologic study was conducted based on detailed data from 210 countries and territories worldwide in April 2020. We used three different formulas to measure CFR and CRR, considering all possible scenarios.

Results: We included information for 72 countries with more than 1,000 cases of COVID-19. Overall, using first, second, and third estimation models, the CFR were 6.22%, 21.20%, and 8.67%, respectively; similarly, the CRR was estimated as 23.21%, 78.86%, 32.23%, respectively. We have shown that CFRs vary so much spatially and depend on the estimation method and timing of case reports, likely resulting in overestimation.

Conclusion: Even with the more precise method of CFRs estimation, the value is overestimated. Case fatality and recovery rates should not be the only measures used to evaluate disease severity, and the better assessment measures need to be developed as indicators of countries’ performance during COVID-19 pandemic.


Keywords


Coronavirus; COVID-19; Case fatality rates; CFRs; Case recovery rates; CRRs

Full Text:

PDF

References


Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. DOI: 10.1038/s41586-020-2012-7

Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020. DOI: 10.1002/jmv.25722

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-544. DOI: 10.1016/S1473-3099(20)30120-1

Abdollahi E, Champredon D, Langley JM, Galvani AP, Moghadas SM. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States. Cmaj. 2020. DOI: 10.1503/cmaj.200711

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246-251. DOI: 10.1016/j.jhin.2020.01.022

Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine. 2020;172(9):577-582. DOI: 10.7326/M20-0504

Bulut C, Kato Y. Epidemiology of COVID-19. Turk J Med Sci. 2020;50(SI-1):563-570. DOI: 10.3906/sag-2004-172

Antunes JL. A dictionary in the dynamics of epidemiology. Rev Bras Epidemiol. 2016;19(1):219-223. DOI:10.1590/1980/5497201600010020

Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. The Lancet Infectious Diseases. 2020;20(7):776-777. DOI: 10.1016/S1473-3099(20)30244-9

Lipsitch M, Donnelly CA, Fraser C, et al. Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks. PLoS Negl Trop Dis. 2015;9(7):e0003846. DOI: 10.1371/journal.pntd.0003846

Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP. Under-reporting and case fatality estimates for emerging epidemics. BMJ. 2015;350:h1115. DOI: 10.1136/bmj.h1115

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Health Care Utilization and Adults with Disabilities. Health-Care Utilization as a Proxy in Disability Determination. Washington (DC): National Academies Press (US); March 1, 2018.

Khafaie MA, Rahim F. Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2. Osong Public Health Res Perspect. 2020;11(2):74-80. DOI: 10.24171/j.phrp.2020.11.2.03

World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation report –43. World Health Organization. March 3, 2020. Accessed December 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200303-sitrep-43-covid-19.pdf.

Centers of Disease Control and Prevention (CDC). United States COVID-19 Cases and Deaths by State. Centers for Disease Control and Prevention. 2020. Accessed March 10, 2020, https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html.

(US) RMAfHRaQ. Registries for Evaluating Patient Outcomes: A User's Guide [Internet]. Data Sources for Registries. 2014; https://www.ncbi.nlm.nih.gov/books/NBK208611/

Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020;150:w20203. DOI: 10.4414/smw.2020.20203

Ghani AC, Donnelly CA, Cox DR, et al. Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease. Am J Epidemiol. 2005;162(5):479-486. DOI: 10.1093/aje/kwi230

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020;20(7):773. DOI: 10.1016/S1473-3099(20)30195-X

COVID TC, Stephanie B, Virginia B, et al. Geographic Differences in COVID-19 Cases, Deaths, and Incidence-United States, February 12-April 7, 2020. MMWR Morb Mort Wkly Rep. 2020;69(15);465-471. DOI: 10.15585/mmwr.mm6915e4

Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489-493. DOI: 10.1126/science.abb3221

Maugeri A, Barchitta M, Battiato S, Agodi A. Estimation of Unreported Novel Coronavirus (SARS-CoV-2) Infections from Reported Deaths: A Susceptible-Exposed-Infectious-Recovered-Dead Model. J Clin Med. 2020;9(5):1350. DOI: 10.3390/jcm9051350

Kelly H, Cowling BJ. Case Fatality: Rate, Ratio, or Risk? Epidemiology. 2013;24(4):622-623. DOI: 10.1097/EDE.0b013e318296c2b6




DOI: https://doi.org/10.5195/cajgh.2021.489

Refbacks

  • There are currently no refbacks.




Copyright (c) 2021 Fakher Rahim, Morteza Abdullatif Khafaie

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.